PAHC vs ZTS
PAHC: Phibro Animal Health is a diversified global provider of animal health and nutritional solutions for livestock and companion animals, supplemented by a specialty chemicals business. ZTS: Zoetis is a leader in the global animal health industry, providing a broad range of innovative medicines, vaccines, and diagnostics for pets and livestock.
Side-by-side fundamentals
| Metric | PAHC | ZTS | Edge |
|---|---|---|---|
| Price as of 2026-10-08 close | $37.40 | $73.08 | |
| Market cap | $1.5B | $30.2B | |
| P/E as of 2026-10-08 | 16.07 | 12.02 | ZTS lower |
| PEG as of 2026-10-08, 3-year EPS CAGR to FY2025 | n/a | 1.17 | |
| Net margin | +6.6% | +28.2% | ZTS higher |
| Gross margin FY2026, SEC XBRL | +33.8% | n/a | |
| Operating margin FY2026, SEC XBRL | +12.8% | n/a | |
| ROE | +25.9% | +80.2% | ZTS higher |
| ROA | +6.6% | +17.3% | ZTS higher |
| Debt / equity as of 2026-09-02 | 2.03 | 2.87 | PAHC lower |
| Revenue growth (YoY) as of 2026-09-02 | +26.0% | +1.4% | PAHC higher |
| Revenue CAGR (3y) SEC XBRL | +15.8% | +5.4% | PAHC higher |
| Dividend yield as of 2026-09-02 | +1.4% | +3.0% | ZTS higher |
| Dividend streak (yrs) SEC XBRL | 12 | 13 | ZTS higher |
| Beta as of 2026-09-02 | 1.06 | 0.56 | |
| 1-year return as of 2026-10-08 close | +0.8% | -49.1% | PAHC higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-02 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-08.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.